Effect of Financial Bonus Size, Loss Aversion, and Increased Social Pressure on Physician Pay-for-Performance: A Randomized Clinical Trial and Cohort Study.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 02 2019
Historique:
entrez: 9 2 2019
pubmed: 9 2 2019
medline: 4 12 2019
Statut: epublish

Résumé

Despite limited effectiveness of pay-for-performance (P4P), payers continue to expand P4P nationally. To test whether increasing bonus size or adding the behavioral economic principles of increased social pressure (ISP) or loss aversion (LA) improves the effectiveness of P4P. Parallel studies conducted from January 1 to December 31, 2016, consisted of a randomized clinical trial with patients cluster-randomized by practice site to an active control group (larger bonus size [LBS] only) or to groups with 1 of 2 behavioral economic interventions added and a cohort study comparing changes in outcomes among patients of physicians receiving an LBS with outcomes in propensity-matched physicians not receiving an LBS. A total of 8118 patients attributed to 66 physicians with 1 of 5 chronic conditions were treated at Advocate HealthCare, an integrated health system in Illinois. Data were analyzed using intention to treat and multiple imputation from February 1, 2017, through May 31, 2018. Physician participants received an LBS increased by a mean of $3355 per physician (LBS-only group); prefunded incentives to elicit LA and an LBS; or increasing proportion of a P4P bonus determined by group performance from 30% to 50% (ISP) and an LBS. The proportion of 20 evidence-based quality measures achieved at the patient level. A total of 86 physicians were eligible for the randomized trial. Of these, 32 were excluded because they did not have unique attributed patients. Fifty-four physicians were randomly assigned to 1 of 3 groups, and 33 physicians (54.5% male; mean [SD] age, 57 [10] years) and 3747 patients (63.6% female; mean [SD] age, 64 [18] years) were included in the final analysis. Nine physicians and 864 patients were randomized to the LBS-only group, 13 physicians and 1496 patients to the LBS plus ISP group, and 11 physicians and 1387 patients to the LBS plus LA group. Physician characteristics did not differ significantly by arm, such as mean (SD) physician age ranging from 56 (9) to 59 (9) years, and sex (6 [46.2%] to 6 [66.7%] male). No differences were found between the LBS-only and the intervention groups (adjusted odds ratio [aOR] for LBS plus LA vs LBS-only, 0.86 [95% CI, 0.65-1.15; P = .31]; aOR for LBS plus ISP vs LBS-only, 0.95 [95% CI, 0.64-1.42; P = .81]; and aOR for LBS plus ISP vs LBS plus LA, 1.10 [95% CI, 0.75-1.61; P = .62]). Increased bonus size was associated with a greater increase in evidence-based care relative to the comparison group (risk-standardized absolute difference-in-differences, 3.2 percentage points; 95% CI, 1.9-4.5 percentage points; P < .001). Increased bonus size was associated with significantly improved quality of care relative to a comparison group. Adding ISP and opportunities for LA did not improve quality. ClinicalTrials.gov Identifier: NCT02634879.

Identifiants

pubmed: 30735234
pii: 2723640
doi: 10.1001/jamanetworkopen.2018.7950
pmc: PMC6484616
doi:

Banques de données

ClinicalTrials.gov
['NCT02634879']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e187950

Références

JAMA. 2005 Oct 12;294(14):1788-93
pubmed: 16219882
N Engl J Med. 2015 Jun 11;372(24):2281-3
pubmed: 26061834
Health Aff (Millwood). 2012 Aug;31(8):1885-94
pubmed: 22786651
JAMA. 2013 Sep 11;310(10):1042-50
pubmed: 24026599
JAMA. 2008 Dec 10;300(22):2631-7
pubmed: 19066383
Health Policy. 2013 May;110(2-3):115-30
pubmed: 23380190
N Engl J Med. 2011 Sep 8;365(10):909-18
pubmed: 21751900
JAMA. 2015 Nov 10;314(18):1926-35
pubmed: 26547464
N Engl J Med. 2008 Sep 18;359(12):1197-200
pubmed: 18799554
N Engl J Med. 2012 Apr 26;366(17):1606-15
pubmed: 22455751
Am J Manag Care. 2016 Sep;22(9):610-2
pubmed: 27662223
Int J Epidemiol. 2014 Jun;43(3):962-70
pubmed: 24603316
N Engl J Med. 2016 Jun 16;374(24):2357-66
pubmed: 27075832
BMC Health Serv Res. 2010 Aug 23;10:247
pubmed: 20731816
Ann Intern Med. 2016 Jan 19;164(2):114-9
pubmed: 26595370
BMC Health Serv Res. 2011 Oct 14;11:272
pubmed: 21999234

Auteurs

Amol S Navathe (AS)

Center for Health Equity Research and Promotion, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania.
Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia.

Kevin G Volpp (KG)

Center for Health Equity Research and Promotion, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania.
Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia.

Kristen L Caldarella (KL)

Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Amelia Bond (A)

Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
Department of Health Care Management, Wharton School of Business, University of Pennsylvania, Philadelphia.

Andrea B Troxel (AB)

Department of Population Health, School of Medicine, New York University, New York, New York.

Jingsan Zhu (J)

Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Shireen Matloubieh (S)

Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Zoe Lyon (Z)

Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Akriti Mishra Meza (A)

Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Lee Sacks (L)

Advocate Physician Partners, Downers Grove, Illinois.

Carrie Nelson (C)

Advocate Physician Partners, Downers Grove, Illinois.

Pankaj Patel (P)

Advocate Physician Partners, Downers Grove, Illinois.

Judy Shea (J)

Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Don Calcagno (D)

Advocate Physician Partners, Downers Grove, Illinois.

Salvatore Vittore (S)

Advocate Physician Partners, Downers Grove, Illinois.

Kara Sokol (K)

Advocate Physician Partners, Downers Grove, Illinois.

Kevin Weng (K)

Advocate Physician Partners, Downers Grove, Illinois.

Nichia McDowald (N)

Advocate Physician Partners, Downers Grove, Illinois.

Paul Crawford (P)

Advocate Physician Partners, Downers Grove, Illinois.

Dylan Small (D)

Department of Health Care Management, Wharton School of Business, University of Pennsylvania, Philadelphia.

Ezekiel J Emanuel (EJ)

Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH